The FDA has cleared a desktop diagnostic test and a related device that can give a rapid diagnosis of one of the most expensive hospital treated conditions in the U.S. – sepsis. The cost to the healthcare system from the infection is more than $20 billion a year.
One year data supports the effectiveness of SinuSys' (Palo Alto, California) Vent-Os sinus dilation system and shows that the technology demonstrated sustained patency of the maxillary sinus ostia at 12 months. The clinical study results were presented at the American Rhinologic Society (Warwick, New York) annual meeting in Orlando this past weekend.
Aortic stenosis is a condition where the aortic valve narrows, thereby limiting blood flow from the aorta to the rest of the body. Untreated, aortic valve stenosis can lead to serious heart problems including heart failure and even death. But a new solution from Medtronic (Minneapolis) could aid in successfully treating the condition – but only if it gains FDA approval first.
